Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine

BACKGROUND: The U.S. Centers for Disease Control and Prevention (CDC) recommended a new regimen for treatment of latent tuberculosis (three months of weekly isoniazid and rifapentine) in late 2011. While completion rates of this regimen were reported to be higher than nine months of isoniazid, littl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: McClintock, Adelaide H., Eastment, McKenna, McKinney, Christy M., Pitney, Caroline L., Narita, Masahiro, Park, David R., Dhanireddy, Shireesha, Molnar, Alexandra
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310079/
https://ncbi.nlm.nih.gov/pubmed/28196479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2245-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados